Open AccessReduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
Author(s) -
David Niklas Springer,
Thomas Perkmann,
Claudia Jani,
Patrick Mucher,
Katja Prüger,
Rodrig Marculescu,
Elisabeth Reuberger,
Jeremy V. Camp,
Marianne Graninger,
Christian Borsodi,
Josef Deutsch,
Oliver Lammel,
Stephan W. Aberle,
Elisabeth PuchhammerStöckl,
Helmuth Haslacher,
Eva Höltl,
Judith H. Aberle,
Karin Stiasny,
Lukas Weseslindtner
Publication year - 2022
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.02129-22
Subject(s) - antibody , virology , antigen , titer , neutralization , covid-19 , neutralizing antibody , biology , immunology , medicine , disease , infectious disease (medical specialty) , pathology